The company is working on an experimental amylin drug to see if it can help people lose weight and manage their diabetes — ...

Revenue and profit forecasts fail to justify the hype baked into Moderna’s share price, according to Citi’s analysts.

Consumer spending snapped back in August after a brief lull, adding to mounting evidence of an acceleration in the U.S.

While investors worry a spike in global bond yields will drag U.S. equities into correction territory, strategists at BofA ...

The carnage in real-estate stocks wasn't letting up on Wednesday as selling in long-dated Treasurys kept yields climbing to ...

JPMorgan has devised a TACO barometer, referring to the expression Trump Always Chickens Out ,as a way to predict the ...

A coalition of carmakers says that in nine months, it has doubled the number of charging ports it offers — although its ...

Analysts will be closely watching Micron's gross margin as a gauge of the company's pricing power. Gross margins measure the ...

So much for a scary September for the stock market. Tech stocks, including semiconductor chip names, helped the S&P 500 move ...

A prominent economist doesn’t fear artificial intelligence, but fully embraces it in portfolios. He feels far differently ...

Investors have become accustomed to returns distorted by artificially low interest rates. 5% on bonds and 6% on stocks are ...

Micron hasn't been able to buy back its stock recently, but soon that could change. Analysts note that later this year, ...